Navigation Links
IBA and Elekta Initiate Global Particle Therapy Program at ASTRO
Date:10/27/2007

ed-value to the world wide proton therapy customers in their daily activities. Complementing this development agreement, the two companies will also join forces in the field of Sales and Marketing, offering optimized commercial solutions to an extended market.

"The IBA proton therapy solution is intrinsically open to interface with any radiation therapy system. However, as cancer centers expect the Oncology Information System (OIS) software and other radiation therapy equipment to operate seamlessly and intelligently with the proton therapy system, the IBA and Elekta joint development will make proton therapy system a benchmark of integration," said Pierre Mottet, Chief Executive Officer of IBA.

"Radiation therapy is currently undergoing rapid transformation in many areas. Intensity modulation, image guidance and workflow enhancing information management systems are today changing the face of cancer care all over the world. Just as Elekta is the driving force behind most of these improvements on the linear accelerator, IBA has demonstrated their dominant leadership in particle therapy technology and our common customers use our products with the IBA system with great satisfaction," said Tomas Puusepp, President and CEO of Elekta. "Thanks to the fact that we share the vision of open systems design approach together with joint informal cooperation in the past, we have been able to quickly find common ground, both technically and commercially. Together, IBA and Elekta will be able to offer an optimal solution for every need at a comprehensive cancer center," Puusepp concluded.

About IBA

IBA delivers solutions of exceptional precision in the fields of cancer diagnosis and therapy. The company also provides sterilization and ionization solutions to improve the hygiene and safety of everyday life. IBA is the undisputed world market leader in Proton Therapy, with more than 50% market share. The company is present in over 40 sites in North America, E
'/>"/>

SOURCE Elekta, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Malvern initiates European user group meetings for chemical imaging
2. Protalix BioTherapeutics, Inc. Receives Approval from the FDA to Initiate a Phase III Clinical Trial of prGCD
3. The International Myeloma Foundation Says Data Reported at a Global Medical Meeting in Greece Demonstrates Improved Survival for a Wide Range of Myeloma Patients
4. New Report Looking at Chiral Technologies Analyzes the Global Market Growth Forecasts Driven By Two Very Important Components as Single Isomer Drugs and Single Enantiomer Pharmaceuticals
5. New Study Reveals Limitations of a Complex and Challenging Global Tuberculosis Drug Marketplace
6. Global Rabies Treatment May be Possible with NanoViricides Drugs
7. Low-Density Cholesterol Subfractions: Not all LDL-C Particles are Created Equal
8. Algeta Demonstrates Targeted Cancer-killing Potential of Novel Alpha Particle Linked Antibodies in Leading Medical Journal Blood
9. Vision Deficit in Retinitis Pigmentosa Mice Corrected with DNA Nanoparticles
10. LigoCyte Pharmaceuticals Presents Data Showing Heterosubtypic Protection Against Influenza Challenge With Virus-Like Particle Immunization
11. Evidence of Nanoparticles Found in Plaque-Filled Arteries
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... -- Varian Medical Systems (NYSE: VAR ), world leader in ... in the Middle East with the ... Arabia . Varian Medical Systems Arabia, the result of ... launched today at a ceremony attended by local dignitaries and ... move represents the next step in our commitment both to ...
(Date:6/3/2015)... South 2015 came to a successful conclusion on April 21. ... has been recognized by industry insiders through its professional and ... medical device manufacturing industry in Southern China ... successful return of the MEDTEC brand to Shenzhen ... 2005. , The most ...
(Date:6/3/2015)... 3, 2015  NxStage Medical, Inc. (Nasdaq: NXTM ... , today announced data that home hemodialysis can ... gallons of water annually by transitioning just 20 ... hemodialysis with the NxStage® System One™.  Industry data ... of water per patient per week, whereas home ...
Breaking Medicine Technology:Varian Establishes Local Entity in Saudi Arabia to Support Expansion in Middle East 2MEDTEC Successfully Returns to Southern China 2MEDTEC Successfully Returns to Southern China 3Home Hemodialysis With NxStage System One Can Save California 221 Million Gallons of Water Annually 2
... SETAUKET, N.Y., Aug. 8 Lixte,Biotechnology Holdings, Inc. ... from each of two different types of drugs ... brain cancers have,activity against human pancreatic cancers in ... President and CEO of Lixte, said, "Lixte previously,reported ...
... Bile Acid-Derived Small Molecules ... Diseases, NEW YORK, Aug. 7 Historically, ... that regulate the absorption of,dietary lipids and cholesterol ... acids have broader systemic endocrine,functions, acting as important ...
Cached Medicine Technology:Lixte Biotechnology Holdings Announces That Novel Compounds Being Developed as Potential Treatments for Brain Tumors Have Positive Activity in a Mouse Model of Human Pancreatic Cancer 2Nature Publication Reports on Key Role of Bile Acids in Glucose Metabolism and Insulin Signaling 2Nature Publication Reports on Key Role of Bile Acids in Glucose Metabolism and Insulin Signaling 3
(Date:6/3/2015)... 2015 The panel of independent experts ... 98 candidates short-listed for the awards presented tonight at ... was fierce but the best-of-the-best can now be revealed ... Group , Volvo swept rivals aside by taking the ... unanimous praise from our panel of expert judges., Stand ...
(Date:6/3/2015)... PA (PRWEB) June 03, 2015 Sitting ... can cause discomfort in the back, neck, shoulders and/or ... other musculoskeletal injuries. In addition, recent research links sitting ... number of chronic diseases. Fortunately, three inventors from Oakville, ... sit at a desk. , They have developed a ...
(Date:6/3/2015)... NY (PRWEB) June 03, 2015 Acne is ... (“bacne”) can be particularly stubborn to eliminate and hard to ... most common in teens and young adults, in the years ... produce sebum, or oil,” says Jayme Bashian, director and lead ... characteristic pimples, blackheads and cysts of acne are caused by ...
(Date:6/3/2015)... These are challenging and unpredictable times for traditional organizations ... business are rewriting the rules for business as we ... traditional businesses to take on a more agile approach ... On top of this there is a growing ... bring new innovation and approaches to business. , The ...
(Date:6/3/2015)... “ Scanalytics ” was featured on NewsWatch as ... latest and coolest technology products available to consumers. Andrew ... conducted the review and shared with viewers how this ... stores. , Tracking statistics in business is invaluable in ... retail this goes a step beyond revenue statistics and ...
Breaking Medicine News(10 mins):Health News:TU-Automotive Awards 2015 winners revealed 2Health News:TU-Automotive Awards 2015 winners revealed 3Health News:Adjustable Height Tabletop Unit Invented by Three InventHelp® Clients (TOR-9278) 2Health News:Back Acne: Tips for Clearer Summer Skin 2Health News:Back Acne: Tips for Clearer Summer Skin 3Health News:Chief Digital Officer of Travelex joins Bayer, Abellio and Just Eat at The Open Mobile Summit London 2Health News:Technology to Analyze Foot Traffic in Retail Stores was featured on NewsWatch Television 2
... benefits of short-term use of hormone therapy in menopausal women ... of life, but they may also shorten their life expectancy ... not to use hormone therapy can be a difficult decision. ... but are the risks worth the benefits? Question researchers . ...
... awareness is needed about the risks of certain prescribed drugs ... // multiple chronic conditions and take several drugs concurrently many ... ,Researchers conducted a study to look at medication prescriptions ... more than 20 percent of the people filled a prescription ...
... with hemophilia arthropathy, a severe form of hemophilia that ... // than other children for developing osteoporosis in ... in preventing osteoporosis from hitting these children, say researchers. ... activities than was previously advised by doctors. An exercise ...
... a tracheoesophageal puncture (TEP), is an incision between the ... small plastic //or silicone valve , researchers say this ... and neck cancer patients who have had their voice ... combined with post operative speech rehabilitation therapy, can provide ...
... have now found a way to genetically engineer the common ... healthy ones intact.// They did this by modifying one gene, ... had to boost the activity of another gene to ensure ... say, “When the virus infects cells, it takes the altered ...
... get a prescription for a potentially lifesaving drug after ... which the heart has trouble pumping blood. // ... who don’t receive an angiotensin-converting enzyme inhibitor are 14-percent ... who do get the drug. ACE inhibitors work by ...
Cached Medicine News:
4 mm x 9 mm tip....
Large. Double-ended. 3 mm pointed end and 5 mm angled end....
4 mm wide tip....
Double-ended. Blunt and semi sharp 5 mm tips. Designated most popular model or size....
Medicine Products: